Literature DB >> 32179925

Smear-positive pulmonary tuberculosis patients with previously abnormal chest radiographs: missed opportunities for early diagnosis.

Lovel Corpuz Galamay1, Cynthia Bin Eng Chee1,2, Kyi Win Khin Mar1, Bih Qin Lau3, Yee Tang Wang1,2.   

Abstract

INTRODUCTION: It is vital to diagnose and treat pulmonary tuberculosis (PTB) early, in the interests of the patient and public health. At the Singapore Tuberculosis Control Unit (TBCU), it was not uncommon to discover abnormal chest radiographs (CXRs) predating their PTB diagnosis by months to years in the electronic medical records (EMRs) of sputum acid-fast bacilli smear-positive patients. Our study explored this observation.
METHODS: The EMRs of sputum smear-positive PTB patients treated at the TBCU from January to July 2014 were viewed for abnormal CXRs preceding their PTB diagnosis. Information in the EMRs pertaining to the indication for the CXRs, radiological reports (including whether the possibility of PTB was stated) and action taken was captured.
RESULTS: Of the 254 sputum smear-positive patients, 108 had previous CXRs in their EMRs, of whom 39 (36.1%) had previous CXRs compatible with PTB. Most of these were performed in tertiary institutions and for reasons unrelated to PTB. No action was taken in response to these CXRs in 24 (61.5%) patients. 27 (69.2%) patients had abnormal CXRs dating back more than six months, with 12 (30.8%) dating back more than 30 months before the PTB diagnosis. Patients aged ≥ 55 years were significantly more likely to have previous CXRs that were compatible with PTB.
CONCLUSION: PTB patients may be asymptomatic or have chronic indolent disease and remain undiagnosed for years. There is a need for vigilance within our healthcare system to seize opportunities for early diagnosis and treatment to prevent the spread of this infectious disease in Singapore. Copyright: © Singapore Medical Association.

Entities:  

Keywords:  acid-fast bacilli; chest radiograph; delayed diagnosis; pulmonary tuberculosis

Mesh:

Year:  2020        PMID: 32179925      PMCID: PMC8801835          DOI: 10.11622/smedj.2020027

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  6 in total

1.  A brave STEP forward--the Singapore Tuberculosis Elimination Programme.

Authors:  C B Chee; S C Emmanuel; Y T Wang
Journal:  Singapore Med J       Date:  1997-09       Impact factor: 1.858

2.  The Singapore Tuberculosis Elimination Programme: the first five years.

Authors:  Cynthia B E Chee; Lyn James
Journal:  Bull World Health Organ       Date:  2003-05-16       Impact factor: 9.408

3.  Delayed tuberculosis diagnosis and tuberculosis transmission.

Authors:  J E Golub; S Bur; W A Cronin; S Gange; N Baruch; G W Comstock; R E Chaisson
Journal:  Int J Tuberc Lung Dis       Date:  2006-01       Impact factor: 2.373

4.  Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Authors:  Payam Nahid; Susan E Dorman; Narges Alipanah; Pennan M Barry; Jan L Brozek; Adithya Cattamanchi; Lelia H Chaisson; Richard E Chaisson; Charles L Daley; Malgosia Grzemska; Julie M Higashi; Christine S Ho; Philip C Hopewell; Salmaan A Keshavjee; Christian Lienhardt; Richard Menzies; Cynthia Merrifield; Masahiro Narita; Rick O'Brien; Charles A Peloquin; Ann Raftery; Jussi Saukkonen; H Simon Schaaf; Giovanni Sotgiu; Jeffrey R Starke; Giovanni Battista Migliori; Andrew Vernon
Journal:  Clin Infect Dis       Date:  2016-08-10       Impact factor: 9.079

Review 5.  The spectrum of latent tuberculosis: rethinking the biology and intervention strategies.

Authors:  Clifton E Barry; Helena I Boshoff; Véronique Dartois; Thomas Dick; Sabine Ehrt; JoAnne Flynn; Dirk Schnappinger; Robert J Wilkinson; Douglas Young
Journal:  Nat Rev Microbiol       Date:  2009-10-26       Impact factor: 60.633

Review 6.  A systematic review of delay in the diagnosis and treatment of tuberculosis.

Authors:  Dag Gundersen Storla; Solomon Yimer; Gunnar Aksel Bjune
Journal:  BMC Public Health       Date:  2008-01-14       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.